ライフサイエンスコーパス: Henoch-Schonlein purpura

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 he aetiopathogenesis of Kawasaki disease and Henoch-Schonlein purpura.

2 information about long-term consequences of Henoch-Schonlein purpura.

3 f the most common vasculitides of childhood: Henoch-Schonlein purpura.

4 ficant percentage of patients afflicted with Henoch-Schonlein purpura.

5 g predisposing factors in the development of Henoch-Schonlein purpura.

6 netic susceptibility and the pathogenesis of Henoch-Schonlein purpura.

7 of childhood, including Kawasaki disease and Henoch-Schonlein purpura.

8 usceptibility, pathogenesis and treatment of Henoch-Schonlein purpura.

9 f nephritis, or alter the natural history of Henoch-Schonlein purpura.

10 Besides studies of Henoch-Schonlein purpura, advances in pediatric vasculit

11 hers have described several polymorphisms in Henoch-Schonlein purpura and Kawasaki Disease as well as

12 most common pediatric vasculitis syndromes, Henoch-Schonlein purpura and Kawasaki disease.

13 ssive diseases: MEFV in Behcet's disease and Henoch-Schonlein purpura, and A1AT in Wegener's granulom

14 ation, such as IgA nephropathy, Tn syndrome, Henoch-Schonlein purpura, and malignant transformation,

15 e genetic susceptibility and pathogenesis of Henoch-Schonlein purpura, but there are still significan

16 l be able to elucidate the manifestations of Henoch-Schonlein purpura, determine appropriate treatmen

17 n concerning the most effective treatment of Henoch-Schonlein purpura has begun to emerge.

18 Studies of Henoch-Schonlein purpura have focused on pathogenesis an

19 Henoch Schonlein Purpura (HSP) is the commonest systemic

20 of a man with a 5-year history of relapsing Henoch-Schonlein purpura (HSP) and macroscopic polyarter

21 Although Henoch-Schonlein purpura (HSP) can occur at any age from

22 tions and molecular changes occurring during Henoch-Schonlein purpura, including cytokines, and endot

23 Childhood Henoch-Schonlein purpura is more frequent in the West Mi

24 Adult-onset Henoch-Schonlein purpura is unusual, but through case st

25 The frequency and ethnic variation of Henoch-Schonlein purpura, Kawasaki disease, and rarer va

26 IgA nephropathy and Henoch-Schonlein purpura nephritis are common glomerular

27 led series of treatment protocols for severe Henoch-Schonlein purpura nephritis are mentioned.

28 e in the pathogenesis of IgA nephropathy and Henoch-Schonlein purpura nephritis has evolved over the

29 Childhood IgA nephropathy and Henoch-Schonlein purpura nephritis have the potential fo

30 sive agents in pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis, recent data indicate

31 to determine the most effective treatment of Henoch-Schonlein purpura, particularly for patients with

32 and existing literature base, The Alder Hey Henoch Schonlein Purpura Pathway was developed, a revise

33 usceptibility, pathogenesis and treatment of Henoch-Schonlein purpura remains incomplete.

34 ition is the hallmark of IgA nephropathy and Henoch-Schonlein purpura, the onset of which often follo

35 The estimated annual incidence of Henoch-Schonlein purpura was 20.4 per 100000, and was hi

36 llustrations of the various complications of Henoch-Schonlein purpura will be reviewed.

37 outcomes of patients with renal disease from Henoch-Schonlein purpura will be summarized.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。